fbpx Skip to main content

Vendor News Article

Catch up on the latest deals and news

COVID-19 Antibody Serology Testing Solutions

  • 2021-01-14
  • Author: Jessica Schneider

Biocom and the Thermo Fisher Scientific™ team are working together yet again to give you access to an unequaled catalog of laboratory items, as well as customer support and competitive pricing to help you stretch your budget as you move forward with the vaccine, therapeutic, and all other research you do every day in response to the COVID-19 pandemic. In order to keep your research progressing, Thermo Fisher Scientific™ is working with their supplier partners to increase their inventories of critical products and develop a portfolio of products to meet rapidly growing COVID-19 serological testing demands, rooted in their commitment to delivering scientific quality at the scale the world needs.

Highlighted below are essential categories to quickly find the products and services you're looking for.

Antibody Tests

Thermo Fisher Scientific has two antibody tests that are currently available under FDA EUA in the US. Both are sold directly through their Specialty Diagnostics Group – Immunodiagnostics channel (links to each product page are listed below).

ELISA test is designed for total antibody detection, thus capturing the body’s production of IgA, IgM, and IgG all in one well. This is a qualitative test.

NOTE: Thermo Fisher Scientific™ has an OmniPATH (quantitative) IgG assay that will be available in the US in 2021*. It is currently available in Europe but has not yet been submitted to the FDA. Click here to see their Press Release for more information.

Fluoroenzymeimmunoassay (FEIA) intended for semiquantitative detection of IgG antibodies to SARS-CoV-2 spike 1 in human serum and plasma.

Antigen Tests

Thermo Fisher Scientific offer both hardware and test kit options Antigen test

If any of our members have an interest in these tests (antigen or antibody), please contact your respective Thermo Fisher Scientific sales team member and they will connect you to their Specialists who will gather additional information and quote these items.

*The path to testing

We help laboratories and clinicians put the patient first. The OmniPATH COVID-19 Total Antibody ELISA Test was developed with the patient’s path to testing in mind, as one piece of a larger portfolio of testing solutions still in development.

We characterize the use of COVID-19 serology in the following four categories: population monitoring, diagnosis, treatment, and immunity.

We characterize the use of COVID-19 serology into the following four categories:

Population monitoring

From epidemiological studies to workforce monitoring, antibody testing is essential when it comes to tracking the pandemic and containing outbreaks. Serological tests can help identify how effective containment strategies have been and help identify what percentage of the population has seen the virus.

Diagnosis

A complex piece of the puzzle that hinges on when patients were first infected; serological testing can fill the gap for when it’s too late to detect live virus with molecular testing.

Treatment

Screening for convalescent plasma therapy relies on serology testing to detect individuals who have mounted a robust immune response to SARS-CoV-2.

Immunity

Although it is still too early to know if antibodies to SARS-CoV-2 confer lasting immunity, serological testing will still be essential for tracking whether natural immunity exists and understanding the efficacy of many vaccines in development.

Log in to your fishersci.com account today to start saving now.

Get the Most out of Your Agreement:

The Thermo Fisher Scientific™ channel is the exclusive Biocom supplier for lab consumables, supplies and equipment, scientific instruments, life sciences tools, supply chain optimization, R&D collaboration, and production solutions.